2012 Annual Meeting

ASENT's 14th Annual Meeting

To view a session, click PPT Icon to view a PowerPoint slide presentation, Audio Icon to hear the audio, and Video Icon to view a video.

Thursday, February 23, 2012

Challenges and Opportunities in Pediatric Drug and Devices Development for Neuro-Psychiatric Diseases: A Cross-Disciplinary Symposium

Challenges and Opportunities in Pediatric Drug and Devices Development for Neuro-Psychiatric Diseases: A Cross-Disciplinary Symposium

Title Speaker(s) Duration Presentation Audio Video
1 - Presidential Welcome Robert Hamill, MD, Richard Keefe, PhD 5:00   Audio  
2 - Session Objectives Atul Mahableshwarkar, MD, Takeda Global Research & Development Inc 5 min Presentation Audio  
3 - Introductory Remarks Thomas Insel, MD 18 min 09 sec Presentation Audio  
Topic 2 - Therapeutics of the Developing Nervous System: Epilepsy as a Model Gregory Holmes, MD 22 min. 22 sec. Presentation Audio  
5 - Specific Consideration for Development in Children and Adolescents: Depression as a Model John March, MD, MPH 23min. 49sec. Presentation Audio  
Thursday Morning Session Q & A Questions and Answers 24min. 50sec.   Audio  
7a - Regulatory Perspective on Pediatric Drug and Device Development - Farchione Tiffany Farchione, MD 14 min. 46sec Presentation Audio  
7b - Regulatory Perspective on Pediatric Drug and Device Development - Kirsten Bowsher Kristen Bowsher, PhD 14 min. 46 sec. Presentation Audio  
8 - PMDA Perspective Yoshiaki Uyama PhD 17min. 13sec. Presentation Audio  
9 - Differences from EMA Perspective Karl Broich, MD 8 min. 22 sec. Presentation Audio  
Perspective Q & A Question and Answers 10 min. 42 sec.   Audio  

Reception & Dinner Session: Product Coverage: Medical Reimbursement and Changes for the Future

Co-Chairs: Mitchell Brin, MD, Allergan, Inc.; Kathleen Clarence-Smith, MD, PhD, KM Pharmaceutical Consulting LLC

Title Speaker(s) Duration Presentation Audio Video
37/17 - Product Coverage: Medical Rembursement and Changes for the Future J. Sanford Schwartz, MD, Wharton School 29 min. 53 sec.      
37/16 - Product Coverage: Medical Reimbursement and Changes for the Future Sir Michael Rawlins 17 min. 30 sec.   Audio  
37 - Dinner Panel Discussion - Schwartz and Rawlins Schwartz_Rawlins 46 min. 12 sec.   Audio  

Friday, February 24, 2012

How Functional Brain Imaging Can Help Speed Drug Development and Clinical Trials

C. Anthony Altar, PhD, Assure Rx Health, Inc.; Jesse Cedarbaum, MD, Cytokinetics, Inc.; William Theodore, MD, NIH

Title Speaker(s) Duration Presentation Audio Video
19 - Pre-clinical Trials in Schizophrenia Dean F. Wong, MD, PhD, Johns Hopkins University Schools of Medicine, Public Health and Business School 42 min. 35 sec. Presentation Audio  
20 - Multiple Sclerosis Richard Rudick, MD, Cleveland Clinic 27 min. 24 sec. Presentation Audio  
21 - Parkinson's Disease David Eidelberg, MD, Feinstein Institute for Medical Research 36 min. 13 sec. Presentation Audio  
22 - Depression Helen Mayberg, MD, Emory University 29 min. 20 sec. Presentation Audio  
23 - Data Reduction: Alzheimer's James Brewer, MD, PhD, University of California, San Diego 31 min. 24 sec. Presentation Audio  
24 - Panel Discussion Discussion Forum 22 min. 34 sec.   Audio  

Saturday, February 25, 2012

Academic Investigators' Symposium: Early Drug Development

Co-Chairs: Mitchell Brin, MD, Allergan, Inc.; Roger J. Porter, MD, University of Pennsylvania; Michael Rogawski, MD, PhD, University of California, Davis; Barbara Slusher, PhD, MBA, Johns Hopkins Brain Science Institute

Title Speaker(s) Duration Presentation Audio Video
27 - The New Paradigm of Academic Drug Discovery Barbara Slusher, PhD, MBA, Johns Hopkins Brain Science Institute 42 min. 26 sec. Presentation Audio  
27b - Funding Academic and Nonprofit Early Drug Development Philip Perera, MD, PhD, Helicon Therapeutics, Inc. 29 min. 46 sec. Presentation Audio  
27c - How Can CROs Contribute to Academic Drug Discovery? James Vornov, MD, PhD, PAREXEL International 18 min. 38 sec. Presentation Audio  
28 - A Chemist's View of a "Druggable" Target For CNS Disorders Takashi Tsukamoto, PhD, Johns Hopkins Brain Science Institute 38 min. 35 sec. Presentation Audio  
29 - What Have We Not Discussed?: The Next Steps Toward the Clinic Roger J. Porter, MD, University of Pennsylvania 10 min. 51 sec. Presentation Audio